计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Information
LDC4297 is a novelCDK7inhibitor (IC50=0.13±0.06 nM for CDK7 versus IC50s between 10 nM and 10,000 nM for all other analyzed CDKs).
Targets
CDK7 (Cell-free assay) 0.13 nM
In vitro
LDC4297 inhibits CDK7 in vitro in the nano-picomolar range. The affinity of LDC4297 for CDK7 proves to be extremely high. The replication of HCMV in cultured primary human fibroblasts (HFFs) is inhibited by LDC4297 in a concentration-dependent manner with a 50% effective concentration (EC50) value of 24.5 ± 1.3 nM. Notably, CDK7 inhibition by LDC4297 is not associated with general cytotoxicity at submicromolar concentrations. In contrast, LDC4297 induces cytotoxicity in a set of tumor cell lines, i.e., already at extremely low, nanomolar concentrations in specific cases. Anti-HCMV activity of LDC4297 is exerted through a multifaceted mode of action that involves an interference with virus-induced Rb phosphorylation.
In vivo
The PK analyses of LDC4297 performed thus far have also been highly promising. An analysis of the PK parameters in CD1 mice reveals positive characteristics after oral administration, as demonstrated for a single-dose treatment (100 mg/kg of LDC4297. The half-life (t1/2z) is determined to be 1.6 h, and a time (Tmax) to a mean peak plasma concentration of 1,297.6 ng/ml is reached 0.5 h after administration, with a continued presence of LDC4297 plasma levels for at least 8 h and a bioavailability of 97.7%.
Cell Research(from reference)
Cell lines:human fibroblasts
Concentrations:0.1 to 50 μM
Incubation Time:3 days
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 三嗪类 |
| 亚类(Subclass) | 氨基三嗪类 |
| 中间层级节点(Intermediate Tree Nodes) | N-脂肪族均三嗪 |
| 直接上位类(Direct Parent) | 2-苄氨基-s-三嗪 |
| 其他上位类(Alternative Parents) | 苯基吡唑类 吡唑并三嗪 吡唑并[1,5-a][1,3,5]三嗪 苄胺 烷氧基-S-三嗪 烷基芳基醚 哌啶类 杂芳族化合物 二烷基胺 氮杂环化合物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 1,3,5-三嗪 - 2-苄基氨基-s-三嗪 - 烷氧基-s-三嗪 - 芳基醚 - 氨基酸 - 芳香族杂多环化合物 - 氮杂环 - 吡唑 - 苯基化合物 - 苄胺 - 乙醚 - 杂芳香族化合物 - 烃衍生物 - 单环苯基基团 - 有机硝基化合物 - 有机氧化合物 - 有机氮化合物 - 有机氧化合物 - 苯基吡唑 - 哌嗪 - 吡唑 - Pyrazolo[1,5-a][1,3,5]triazine - 吡唑并三嗪 - 二级脂肪胺 - 醛基 |
| 描述(Description) | 该化合物属于有机化合物中的2-苄基氨基-s-三嗪类。这类芳香杂环化合物含有S-三嗪环,其2位被苄基胺取代。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H302: 吞食有害
H315: 引起皮肤刺激
H319: 引起严重眼睛刺激
H335: 可能引起呼吸道刺激
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾
P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。